{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:20:11Z","timestamp":1793830811476,"version":"4.6.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00210-025-03855-z","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:12:57Z","timestamp":1739952777000},"page":"10295-10303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of nebivolol, carvedilol, and bisoprolol for adverse clinical outcomes among patients with heart failure\u2014a real-world nationwide investigation"],"prefix":"10.1007","volume":"398","author":[{"given":"Wei-Syun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"21","key":"3855_CR1","first-page":"376","volume":"117","author":"D Berliner","year":"2020","unstructured":"Berliner D, H\u00e4nselmann A, Bauersachs J (2020) The treatment of heart failure with reduced ejection fraction. Dtsch Arztebl Int 117(21):376\u2013386","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"3855_CR2","first-page":"2453","volume":"62","author":"WE Chavey 2nd","year":"2000","unstructured":"Chavey WE 2nd (2000) The importance of beta blockers in the treatment of heart failure. Am Fam Physician. 62(11):2453\u201362","journal-title":"Am Fam Physician."},{"issue":"3","key":"3855_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML (2011) Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 20(3):236\u2013242","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"3855_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2188\/jea.JE20140076","volume":"24","author":"CL Cheng","year":"2014","unstructured":"Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH (2014) Validation of acute myocardial infarction cases in the National Health Insurance Research Database in Taiwan. J Epidemiol 24(6):500\u2013507","journal-title":"J Epidemiol"},{"key":"3855_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijcard.2015.07.075","volume":"201","author":"CL Cheng","year":"2015","unstructured":"Cheng CL, Chien HC, Lee CH, Lin SJ, Yang YH (2015) Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan. Int J Cardiol 201:96\u2013101","journal-title":"Int J Cardiol"},{"issue":"3","key":"3855_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","volume":"26","author":"MD Flather","year":"2005","unstructured":"Flather MD, Shibata MC, Coats AJ et al (2005) SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 26(3):215\u2013225","journal-title":"Eur Heart J."},{"issue":"12","key":"3855_CR7","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/01.CIR.0000065187.80707.18","volume":"107","author":"M Gheorghiade","year":"2003","unstructured":"Gheorghiade M, Colucci WS, Swedberg K (2003) Beta-blockers in chronic heart failure. Circulation. 107(12):1570\u20131575","journal-title":"Circulation."},{"issue":"18","key":"3855_CR8","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 145(18):e895\u2013e1032","journal-title":"Circulation."},{"issue":"9","key":"3855_CR9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1234","volume":"20","author":"M Koradji","year":"2018","unstructured":"Koradji M, B\u00f6hm M, Borer JS et al (2018) Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis. Eur J Heart Fail 20(9):1315\u20131322","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"3855_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S1388-9842(03)00054-0","volume":"5","author":"S Nodari","year":"2003","unstructured":"Nodari S, Meta M, Dei Cas L (2003) Beta blocker treatment of patients with diastolic heart failure and arterial hypertension A prospective, randomized, comparison of the long-term effects of atenolol vs nebivolol. Eur J Heart Failure 5(5):621\u2013627","journal-title":"Eur J Heart Failure"},{"issue":"27","key":"3855_CR11","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et al (2016) ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 37(27):2129\u20132200","journal-title":"Eur Heart J."},{"issue":"27","key":"3855_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail 37(27):2129\u20132200","journal-title":"Eur J Heart Fail"},{"key":"3855_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/VHRM.S20669","volume":"8","author":"JE Toblli","year":"2012","unstructured":"Toblli JE, DiGennaro F, Giani JF, Dominici FP (2012) Nebivolol: impact on cardiac and endothelial function and clinical utility. Review Vasc Health Risk Manag 8:151\u2013160","journal-title":"Review Vasc Health Risk Manag"},{"issue":"5","key":"3855_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/hc3001.094207","volume":"104","author":"N Tzemos","year":"2001","unstructured":"Tzemos N, Lim PO, MacDonald TM (2001) Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation. 104(5):511\u2013514","journal-title":"Circulation."},{"issue":"5","key":"3855_CR15","first-page":"647","volume":"3","author":"A Veverka","year":"2007","unstructured":"Veverka A, Salinas JL (2007) Nebivolol in the treatment of chronic heart failure. Vasc Health Risk Manag. 3(5):647\u2013654","journal-title":"Vasc Health Risk Manag."}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03855-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03855-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03855-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:08:23Z","timestamp":1757138903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03855-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3855"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03855-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of China Medical University and Hospital (CMUH110-REC1-038(CR-3)).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not required","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not required","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}